Get the Stockscreener App
0.7497
8.67%
0.0598
Bone Biologics Corp stock is traded at $0.7497, with a volume of 167.34K.
It is up +8.67% in the last 24 hours and up +12.10% over the past month.
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
See More
Previous Close:
$0.6899
Open:
$0.6899
24h Volume:
167.34K
Relative Volume:
1.95
Market Cap:
$2.36M
Revenue:
-
Net Income/Loss:
$-4.14M
P/E Ratio:
-0.1034
EPS:
-7.2511
Net Cash Flow:
$-4.79M
1W Performance:
+3.76%
1M Performance:
+12.10%
6M Performance:
-44.88%
1Y Performance:
-58.35%
1-Day Range:
$0.685
$0.765
1-Week Range:
$0.6292
$0.765
52-Week Range:
$0.57
$4.25
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.7497 | 2.36M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Bone Biologics Corp Stock (BBLG) Latest News
Trend Tracker for (BBLGW) - news.stocktradersdaily.com
Orthobiologics Market Grows Strong with Expanding Use in Sports - openPR.com
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - IT News Online
Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe - Yahoo Finance
Bone Biologics (OTC:BBLG) Trading Down 0.4% – Should You Sell? - Defense World
BBLG stock touches 52-week low at $0.57 amid market challenges By Investing.com - Investing.com South Africa
BBLG stock touches 52-week low at $0.57 amid market challenges - Investing.com Australia
Orthobiologics Market Set to Witness Significant Growth - openPR.com
When (BBLGW) Moves Investors should Listen - news.stocktradersdaily.com
BBLG stock touches 52-week low at $0.7 amid market challenges - Investing.com Canada
BBLG stock touches 52-week low at $0.7 amid market challenges By Investing.com - Investing.com South Africa
Bone Biologics (OTC:BBLG) Trading 1.9% Higher – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bone Biologics sets date for 2025 annual meeting - Investing.com
Top Trend In Orthobiologics Devices And Equipment Market 2025: Biodegradable Implants Transforming Orthobio... - WhaTech
Orthobiologics Market Future Business Opportunities - openPR.com
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors - The Malaysian Reserve
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading 1.2% Higher – Here’s Why - Defense World
MTF Biologics Collaborates with Kolosis BIO to Boost DBX Brand - World Business Outlook
MTF Biologics Expands Partnership with Kolosis BIO to Strengthen DBX Brand - StreetInsider.com
TETROUS®, INC. SUCCESSFULLY CLOSES FINANCING ROUND, SECURING ADDITIONAL CAPITAL FOR FUTURE GROWTH - PR Newswire
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Down 15.9% in February - Defense World
BBLG stock touches 52-week low at $0.8 amid market challenges - Investing.com
Orthobiologics Market Generated Opportunities, Future Scope - openPR
BBLG: Funding Looks Good as Trials Continue - Research Tree
Bone Biologics Corp SEC 10-K Report - TradingView
Orthobiologics Market : Comprehensive Overview, Trends, and Future Outlook 2025-2035 - PharmiWeb.com
Key Bone Void Fillers Market Trend 2025-2034: Advancements In Bone Healing Through Carbohydrate Polymer Tec... - WhaTech
Bone Biologics (BBLG) Expected to Release Quarterly Earnings on Wednesday - Defense World
Biodexa Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:BDRX - Benzinga
Bone Biologics (NASDAQ:BBLG) Stock Quotes, Forecast and News Summary - Benzinga
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Trevi Therapeutics Inc (TRVI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
OMI’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
CNQ’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
Edison International (EIX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
BBLG’s Stock Journey: What Investors Need to Know About Bone Biologics Corp’s Performance - The InvestChronicle
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Up 9.8% in January - Defense World
(BBLGW) Technical Pivots with Risk Controls - Stock Traders Daily
Spine Biologics Market Research to 2030: Expansion Fueled - GlobeNewswire
Bone Biologics (OTC:BBLG) Trading Down 6.9% – Here’s Why - Defense World
Bone Growth Products Market Size is Expected to Reach USD 1.81 Billion by 2033, Growing at a CAGR of 3.40%: Straits Research - Ortho Spine News
(BBLGW) Trading Report - Stock Traders Daily
An innovative advance in bone grafting: initial clinical results using a novel integrative bone graft in spinal fusion - Frontiers
Bone Biologics (OTC:BBLG) Trading Up 13% – Should You Buy? - Defense World
(BBLGW) Trading Advice - Stock Traders Daily
What Analysts Think About Bone Biologics Corp (NASDAQ: BBLG)’s Potential Raise - Stocks Register
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):